PRimage.jpg
ENOVIX INVESTOR ALERT: Kaplan Fox & Kilshiemer LLP Notifies Enovix Investors of a Class Action Lawsuit and Upcoming Deadline
18 janv. 2023 17h56 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Jan. 18, 2023 (GLOBE NEWSWIRE) --  Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Enovix Corp. (“Enovix” or “Company”) (NASDAQ: ENVX)...
PRimage.jpg
Kaplan Fox Reminds Investors with Losses in Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) of February 3, 2023 Lead Plaintiff Deadline
13 janv. 2023 23h00 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) filed a proposed class action suit in the United States District Court for the Southern District of...
PRimage.jpg
SOUTHWEST AIRLINES: Kaplan Fox Investigates Southwest Airlines Co.
06 janv. 2023 11h15 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Southwest Airlines Co. (“Southwest” or “Company”)...
PRimage.jpg
SI INVESTOR ALERT: Kaplan Fox & Kilshiemer LLP Notifies Silvergate Investors of a Class Action Lawsuit and Upcoming Deadline
05 janv. 2023 14h34 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) notifies investors in Silvergate Capital Corporation (“Silvergate” or “Company”) (NYSE: SI) of a...
PRimage.jpg
Kaplan Fox Reminds Investors with Losses in Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) of Upcoming Lead Plaintiff Deadline
20 déc. 2022 17h51 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) filed a proposed class action suit in the United States District Court for the Southern District of...
PRimage.jpg
INVESTOR ALERT: Kaplan Fox Investigates Potential Securities Fraud at Singularity Future Technology Ltd (SGLY)
12 déc. 2022 10h32 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors of Singularity Future Technology Ltd...
Kaplan Fox Files Cla
Kaplan Fox Files Class Action to Recover Losses for Investors Who Purchased Common Stock of Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI)
05 déc. 2022 21h40 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has filed a proposed class action suit in the United States District Court for the Southern District...
UNISYS CORPORATION I
UNISYS CORPORATION INVESTOR ALERT: Kaplan Fox & Kilshiemer LLP Notifies Unisys Investors of a Class Action Lawsuit and Upcoming Deadline
02 déc. 2022 21h10 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Unisys Corporation (“Unisys” or the “Company”) (NYSE:...
Kaplan Fox Continues
Kaplan Fox Continues to Investigate Potential Securities Fraud at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) - INVESTOR UPDATE
02 déc. 2022 15h32 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing to investigate claims on behalf of investors in Spectrum Pharmaceuticals, Inc....
Y-mAbs Therapeutics,
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investor Update: Kaplan Fox Continues to Investigate Potential Securities Fraud
02 déc. 2022 13h10 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of claims on behalf of investors in Y-mAbs Therapeutics, Inc....